ATLANTA, March 2, 2021 /PRNewswire/ — Oncology Analytics, a leading data analytics and technology-enabled services company purpose-built for oncology, leveraged an ongoing commitment to innovation and patient-first treatment approach to achieve key growth milestones for fiscal year 2020.
Over the past twelve months, Oncology Analytics:
In 2020, Oncology Analytics successfully implemented its OneUM™ platform with Harvard Pilgrim Health Care and Gateway Health as part of multi-year partnership agreements. The company also launched its Pharmacy Consulting Services to help health plans navigate the anti-cancer drug market by partnering with board-certified oncology PharmDs in areas such as improving oncology formulary strategy, creating biosimilar strategies and evaluating oncology drug policies.
Last year also marked the second year in a row the company was named to the Digital Health 150, an annual ranking that recognizes the most promising private companies creating innovative products and services to transform the healthcare industry.
“With 25 new anti-cancer drugs approved by the FDA and 66 new FDA indications in 2020, it is incumbent on health plans and providers to work together to ensure the appropriate therapies are being reviewed and approved for patients,” said Rick Dean, Oncology Analytics’ CEO. “Our unwavering focus on innovation and oncology will ensure that we can meet the demand and continue to grow and service our health plans’ customers, their network providers, and the patients that depend on all of us to do what is in their best interest.”
About Oncology Analytics
Oncology Analytics, Inc. provides health plans, providers, and patients with a data-driven, utilization management solution that delivers real-world, evidence-based analytics focused exclusively for oncology. Used by physicians to support 6 million health plan members in the US and Puerto Rico, the Oncology Analytics e-Prior Authorization platform covers the full spectrum of therapeutics, across all cancer types and stages, including chemotherapy, radiation therapy, precision medicine, targeted therapy, and supportive care. The extensive pathway library is continuously updated with the latest evidence-based protocols, which provides the most current options for value-based treatment paths for every patient case. For more information, please visit www.oncologyanalytics.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/ongoing-innovation-patient-first-approach-drives-successful-2020-for-oncology-analytics-301237966.html
SOURCE Oncology Analytics, Inc.
GE HealthCare and the Department of Radiology at Stanford Medicine aim to explore total body…
GE HealthCare and the Department of Radiology at Stanford Medicine aim to explore total body…
NEW YORK--(BUSINESS WIRE)--Surgimate, a leading provider of surgical coordination and scheduling software in the U.S.,…
Industry vendors team up to support radiation oncology clinics nationwide BOONE, N.C., June 19, 2025…
CLEVELAND, June 19, 2025 /PRNewswire/ -- PartsSource, the leading technology and enterprise software platform for…
Tenured healthcare executive to succeed Founder Elisabete Miranda Smith to build on 25-year legacy of…